An emerging wave of bioelectronic medicine is changing the way we treat disease, targeting everything from arthritis and diabetes to cancer and Crohn’s disease. Andrew Wade reports.
Electromedical Technologies and Nazarbayev University Complete Agreement to Expand Promising Joint Research Programs
News provided by
Share this article
- Stage I research programs designed to study how electro-modulation communicates to cells
- Program objective to d
and generating cellular response
agreement EMED and Nazarbayev plan to begin the IDE process with the FDA
SCOTTSDALE, Ariz., June 3, 2021 /PRNewswire/ Electromedical Technologies, Inc. (OTCQB: EMED) (the Company ), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared
WellnessPro+®, is pleased to announce that the Company recently completed an agreement with Nazarbayev University to expand its Stage I collaborative research programs. These Stage I programs will study how electro-modulation communicates to cells by modifying intracellular signaling events and altering physiological cellular response.
Electroceuticals, the bioelectronic medicine of the future zmescience.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zmescience.com Daily Mail and Mail on Sunday newspapers.